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ORIGINAL ARTICLE

ASSESSING NUTRITIONAL STATUS OF CRITICALLY ILL PATIENTS
USING SERUM PREALBUMIN LEVELS
Khushbakht Arbab, Hafsa Majid*, Lena Jafri*, Bushra Akram††, Ahmed Raheem*,
Bushra Jamil**, Madiha Hashmi***, Aysha Habib Khan*
Department of Pathology, Combined Military Hospital (CMH) Quetta, *Department of Pathology & Laboratory Medicine,
**Department of Medicine, ***Department of Anaesthesiology, Aga Khan University, Karachi, ††Dow University of Health Sciences,
Karachi-Pakistan

Background: Malnutrition in hospitalized patients, contributes to poor outcomes. Biomarker serum
prealbumin, can prevent the complications by commencement of nutritional support to improve clinical
outcomes. This study was designed to assess the association between low serum prealbumin level (<18
mg/dl), with length of stay and all cause intensive care unit mortality. Methods: This cross-sectional
study was conducted from July 2016 to July 2017 at Aga Khan University Hospital Karachi Pakistan.
All consecutive patients, aged between 18 to 70 years, admitted in medical or surgical intensive care
unit were included. Demographic, clinical history and blood samples for analysing serum prealbumin
were obtained on first day of admission. Patients were categorized into two groups based on their serum
prealbumin level (taking <18 mg/dl as low). Results: A total of 139 patients were included in this
study; 95 (68.3%) were male. Median (Q3-Q1) prealbumin level of 12.3 mg/dl (18.8–8.7) was
observed with low prealbumin level (<18 mg/dl) in 100 (71.9%) patients. All-cause mortality was
observed in 26 (26.0%) patients, mortality rate was significantly higher in patients with low prealbumin
level (26.0% vs. 17.9%), p-value =0.31). Hospital and intensive care unit length of stay were
statistically insignificantly different between the two groups with p-values of 0.27 and 0.44
respectively. Conclusion: We did not find association of low serum prealbumin with length of stay and
mortality. Further research is warranted for the assessment of prealbumin as independent predictor of
ICU mortality.
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INTRODUCTION
According to American Society of Parenteral and
Enteral Nutrition, malnourishment is defined as “an
acute, subacute or chronic state of nutrition, in which a
combination of varying degrees of overnutrition or
undernutrition with or without inflammatory activity led
to a change in body composition and diminished
function”.1 An estimated 2 billion world population is
malnourished, which is increasing globally but
especially in developing countries.2
Poor nutritional status contributes to poor
outcomes like; prolonged length of stay (LOS) in
hospital, increased readmission rates, occurrence of
disease complications. This in turn leads to increased
overall cost of care and all-cause mortality. Incidence of
malnutrition in hospitalized patients is estimated to be as
high as 40–50% of all hospitalized patients.3 If
identified early, malnourishment in hospitalized patients
can be prevented by early commencement of nutritional
support leading to improvement in clinical outcomes
and reduction in overall cost.
There are different methods used to classify
malnutrition ranging from clinical signs and symptoms
to anthropometric measures and biochemical tests.

178

Despite all the advancements in field of healthcare, there
is variability in malnourishment assessment techniques
and it is dependent on expertise of personnel assessing
the nutritional status. Serum albumin is a widely used
indicator of the status of nutrition4 but due to its long
half-life of 3–4 weeks; acute changes in nutritional
status cannot be determined. There is a need to identify
accurate, rapid and sensitive biomarkers for nutritional
assessment.
Prealbumin also known as transthyretin
provides a recent index of nutritional status. However,
its predictive value in assessing nutritional status of
critically ill patients is not well studied. Thus, this study
was designed to assess clinical utility of prealbumin in
identifying the nutritional status in critically ill patients
and evaluate its association with LOS in hospital and
all-cause mortality.

MATERIAL AND METHODS
This cross-sectional study was conducted at
Departments of Pathology and Laboratory Medicine,
Medicine and Anaesthesiology of Aga Khan University
Hospital Karachi Pakistan. Approval of institutional
ethical review committee was taken before
commencement of the study (ERC ID: 3930-Pat-ERC-
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15). Patient admitted to intensive care unit (ICU) within
12 hours of admission from July 2016 to July 2017 were
invited to participate in the study after informed consent
from the legal care taker or guardian. Patients with
history of chronic liver disease, on dialysis, with history
of alcohol, and prednisolone intake and diagnosed
nephrotic syndrome were excluded. Also, the patients
admitted to wards and then shifted to ICU due to
deterioration of underlying condition were excluded to
decrease effect of prolong hospital admission. Patients
were included before initiation of any nutritional
support. One hundred and thirty-nine patients were
finally analysed and followed up till the patients were
discharged from ICU or after shifted to ward, special
care or expired during hospitalization.
Their demographic details such as gender, age,
weight and height were recorded using structured
questionnaire and BMI was calculated. Patient’s last two
months clinical history with regards to hospitalization,
weight loss, history of vomiting, diarrhoea, anaemia,
loss of appetite, and difficulty in chewing and
swallowing was taken along with LOS in ICU, LOS in
hospital and mortality status. Five millilitres of blood
sample for prealbumin was collected in a gel tube and
stored at -80oC until analysis. All enrolled patients were
observed during their hospital stay for ICU LOS,
hospital LOS and all-cause mortality.
Serum prealbumin was analysed by
nephelometric method on Image 800 Chemistry
analyser (Beckman Coulter Inc. NY, US) using
Beckman Coulter’s serum prealbumin kit. For
assessing system performance and validating results,
three levels of manufacturer provided internal quality
controls were run with each batch of prealbumin.
Serum prealbumin cut-off of >18mg/dl was labelled
as normal.
Collected data were entered and analysed
using Statistical Package for the Social Sciences
(SPSS version 21 and R version 3.4.3). Normality of
distribution for continuous variables was assessed
using Shapiro-Wilk test and appropriate median (Q3Q1) was calculated. Categorical variables were
expressed as frequency and percentage. Patients were
categorized into two groups based on their
prealbumin level (<18 mg/dl and ≥18 mg/dl).
Association of low prealbumin level (<18 mg/dl)
with categorical variables were examined using the
Chi-square test. The association between continuous
variables and low prealbumin level were examined
using the Mann-Whitney test. A p-value of ≤0.05 was
taken as criteria for statistical significance. Univariate
and multivariate logistic regression was performed
taking low prealbumin levels as independent variable.
Two-sided p-value of ≤0.05 was taken as criteria for
statistical significance.

RESULTS
A total of 139 patients were included in this study, of
which 95 (68.3%) were male. Median age of the
patients was 47 years (64–32) and median BMI was 26
kg/m² (29.4–24). Majority of the patients 58 (41.7%)
were either overweight or obese. Median prealbumin
level was 12.3 mg/dl (18.8–8.7). Low prealbumin level
(<18 mg/dL) was seen in 100 (71.9%) patients. Fiftytwo (37.4%) of patients, belonged to service of
neurosurgery, followed by surgery 29 (20.9%), general
medicine 54 (38.8%), and orthopaedics’ 4 (2.9%). All
cause ICU mortality was observed in n=33 (23.7%) of
the study patients. Demographic and other
characteristics of the patients are presented in table-1.
Comparison of association of clinical
characteristics and study outcomes with low and optimal
prealbumin are presented in table-2.
Significant association of low prealbumin level
was observed with history of hospitalization and
vomiting in past two months. All-cause mortality was
observed in 33 (23.7%) patients; mortality rate was
higher in patients with low prealbumin as compare to
those with level more than 18mg/dl but it was not
statistically significant {26 (26%) vs. 7 (17.9%) p-value
= 0.31)}. Median hospital and ICU length of stay were
different between the two groups (p value >0.05).
Median prealbumin level was found to be significantly
higher in survived patients, 13.9 mg/dl (19.1–10.3) vs.
9.7 mg/dl (16.8–6.8), as compared to patients who
expired (p-value of 0.02).
After adjusting for all the potential factors in
multivariate linear regression analysis, none of the
factors were found to correlate with prealbumin. Table-3
depicts the univariate and multivariate analysis of low
prealbumin blood level against different baseline
characteristics.
Table-1: Demographic and clinical characteristics of
the patients admitted to ICU (n=139)
Characteristics

Frequency (%) or Median
(IQR)

Gender
Male
95 (68.3%)
Female
44 (31.7%)
*Age years
47(64-32)
Up to 50
73 (52.5%)
≥ 50
66 (47.5%)
*Body Mass Index (BMI) kg/m2
26.0(29.4-24.0)
Underweight [<18.5]
5 (3.6%)
Healthy [18.5 <23]
19 (13.7%)
Overweight [23- 27]
58 (41.7%)
Obese [BMI ≥ 27]
57 (41.0%)
*Prealbumin mg/dl
12.3 (18.8-8.7)
<18
100 (71.9%)
≥18
39 (28.1%)
*Values are expressed as Median (IQR = Interquartile Range) as
*hypothesis of the normality of the distribution was rejected with
Shapiro-Wilk test p-value of <0.001
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Table-2: Comparison of clinical characteristic & study outcomes of patients admitted to ICU with low &
optimal prealbumin levels (n=139)
Frequency (%)
n=139
Past two months clinical history
Past Hospitalization
Weight Loss
Vomiting
diarrhoea (2–3 episodes\day)
Loss of Appetite
Difficulty in Chewing
Difficulty in Swallowing
Anaemia
Study Outcomes
LOS in Hospital (days) Median (IQR)
LOS in ICU (days) Median (IQR)
All cause ICU mortality

31 (22.3%)
50 (36%)
34 (24.5%)
16 (11.5%)
44 (31.7%)
9 (6.5%)
8 (5.8%)
38 (27.3%)

Prealbumin Level
<18mg/dL
≥18mg/dL
n = 100
n = 39
27 (27%)
38 (38%)
29 (29%)
14 (14%)
34 (34%)
5 (5%)
7 (7%)
26 (26%)

4 (10.3%)
12 (30.8%)
5 (12.8%)
2 (5.1%)
10 (25.6%)
4 (10.3%)
1 (2.6%)
12 (30.8%)

12 (18–8)
12 (18–8)
11 (16–7)
6 (9–3)
6 (10–3)
5 (7–4)
33 (23.7%)
26 (26.0%)
7 (17.9%)
*Statistically significant at 0.05 level of significance
**p-values are based on chi-square test for categorical variables and Mann-Whitney test for continuous variables
LOS = Length of stay
ICU = Intensive care unit
IQR = Interquartile Range

**p-value

0.03*
0.42
0.04*
0.14
0.34
0.25
0.31
0.57
0.27
0.44
0.31

Table-3: Univariate and multivariate analysis of low prealbumin
Factors

Univariate Analysis
OR [95% CI]
p-value

Demographics
Male
Age > 50 years
BMI ≥ 23 kg/m2
Past two months clinical history
Past Hospitalization
Weight Loss
Vomiting
Diarrhoea
Loss of Appetite
Difficulty in Chewing
Difficulty in Swallowing
Anaemia
All cause ICU Mortality
Dependent variable = Low Prealbumin
OR=Odds Ratio, CI = Confidence interval
*Statistically significant at 5% level of significance

1.11 [0.51–2.45]
1.67 [0.78–3.54]
0.83 [0.3–2.27]

0.79
0.18
0.71

1.45 [0.6–3.49]
1.52 [0.66–3.48]
1 [0.32–3.14]

0.41
0.32
0.99

3.24 [1.05–9.97]
1.38 [0.63–3.04]
2.78 [0.99–7.81]
3.01 [0.65–13.92]
1.49 [0.65–3.42]
0.46 [0.12–1.81]
2.86 [0.34–4.04]
0.79 [0.35–1.78]
1.61 [0.63–4.08]

0.04*
0.42
0.05
0.15
0.34
0.26
0.33
0.57
0.31

2.82 [0.79–10.05]
1.27 [0.46–3.5]
2.95 [0.95–9.15]
2.37 [0.43–13.24]
0.73 [0.25–2.18]
0.47 [0.1–2.25]
3.01 [0.32–28.61]
0.66 [0.26–1.65]
1.56 [0.56–4.31]

0.11
0.63
0.06
0.32
0.57
0.34
0.33
0.37
0.39

DISCUSSION
Since long serum albumin have been utilized by
physicians for monitoring or evaluation of nutritional
status. However, it has proved to be an ineffective
measure for assessing recent changes in nutritional
status, owing to its large plasma pool and long halflife of 3–4 weeks. On the other hand, prealbumin, has
a half-life in plasma of 24–48 hours, which in
comparison to albumin is much shorter. Hence it is
relatively more responsive to alterations in energyprotein status in comparison to albumin and provides
a better reflection of dietary intake that was recent
rather than the overall status of the nutrition.5 A raise
in prealbumin can be expected within 4 days after
nutritional support has been provided complemented
with the intake of a high calorie/high protein
formula.6
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Multivariate Analysis
OR [95% CI]
p-value

Malnourishment is a common finding in hospitalized
patients and its early identification and correction is
imperative for the better outcome of the patients.
Low prealbumin is reported to be associated with
higher in-hospital or short-term mortality and post
procedural complication such as infection, extended
hospital stays and mechanical support in patients with
various underlying diseases.7–11 This study was an
attempt to assess the association between low
prealbumin (<18 mg/dl), with LOS and all-cause
mortality in our population.
In present study, 71.9% of the patients had
low levels of prealbumin. Association of prealbumin
was observed with past two month’s history of
hospitalization and vomiting. Lower prealbumin
values in patients who expired as compared to those
who survived were also noted. While LOS in ICU
and hospital were longer in subjects with low
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prealbumin (<18 mg/dl) levels; 6 days (10–3) and 12
days (18–8) compared to patients with optimal
prealbumin 5 days (7–4) and 11days (16–7)
respectively. However, none of the factors were
significantly associated with serum prealbumin level
in the regression model in this study.
Previous study by Cheng V et al12 reported
that low prealbumin was associated with critically ill
trauma patients had high rate infections (p<0.001),
more mortality (p-value 0.007), extended hospital
stays (p<0.001), and longer ICU stay (p<0.001).
Another study by Avram et al13 documented that
serum prealbumin was an independent forecaster of
mortality in patients suffering from peritoneal
dialysis. Similarly, another study by Yang HT et al14
on massively-burned patients observed that serum
prealbumin was independently associated with
mortality. A study on critically ill patients by
Devakonda A et al15 found excellent concordance
between protein energy malnutrition and serum
prealbumin, additionally prealbumin levels correlated
with mortality, ICU and hospital LOS. There are
some limitations to our study; small sample size,
single centre cross-sectional study design while serial
monitoring may serve as a better predictor.

Funding disclosure: The study was supported by
Resident Research Grant from Department of
Pathology & Laboratory Medicine, Aga Khan
University.
Conflict of Interest: All authors have no conflict of
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